Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.
Affinity maturation of antibodies requires localized hypermutation and antigen selection. Hypermutation is particularly active in certain regions (notably the CDRs of light and heavy chains) due to the local accumulation of hot spots. We have now analyzed the role of individual nucleotides in the origin of hot spots and show that mutability is largely defined by the nucleotide sequence. We compared the mutability profile of wild-type and modified kappa transgenes that contain silent mutations in the CDR1 segment. We found a new hot spot created at the third base of Ser-31 when its wild-type AGT codon was substituted by AGC. Two major hot spots associated with this AGC vanished when Ser-31 was encoded by the synonymous TCA. In addition to these, which were the most prominent changes, there were compensatory alterations in mutability of residues not directly related to the introduced silent mutations, so that the average hypermutation remained constant. Thus, mutations arising early in the immune response, even silent ones, could affect the mutability of critical residues and alter the pattern of affinity maturation. When analyzing hybridomas, we detected such alterations, but they seemed to better correlate with changes in average rather than local mutation rates. Overall, this paper shows how evolution could have optimized the mutability of individual residues to minimize deleterious mutations. Thus, the optimal strategy for affinity maturation may involve the incorporation of multiple point mutations before antigen selection of the relevant cells.
Goyenechea
B
B
Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.
Milstein
C
C
D000818:Animals; D001483:Base Sequence; D003062:Codon; D017931:DNA Primers; D005803:Genes, Immunoglobulin; D007135:Immunoglobulin Variable Region / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008822:Mice, Transgenic; D016297:Mutagenesis, Site-Directed; D010581:Peyer's Patches / Q000276:immunology*; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D051381:Rats; D015183:Restriction Mapping; D012694:Serine
D003062:Codon; D017931:DNA Primers; D007135:Immunoglobulin Variable Region; D012694:Serine